Cory Dunn serves as a U.S.-based marketing and business development consultant and advisor to BCAL Diagnostics. She brings 15+ years clinical diagnostics experience across women’s health and oncology for liquid biopsy- and tissue-based testing. Most recently, Cory served in pivotal leadership and independent contributing roles to develop, launch and grow oncology diagnostics products at PreludeDx, Biocept, and Decipher Biosciences. She holds graduate degrees from Stanford University and U.C. San Diego.
